Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

NCT: NCT06203938 · RECRUITING

NCT IDNCT06203938
StatusRECRUITING
Start Date2025-01-13
SponsorFrancisco Gonzalez-Lima, PhD (OTHER)
First posted
Last updated

Brief Summary

The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑